Latest Technology News

Cochlear Limited reported a solid FY25 with 4% revenue growth and a 1% rise in underlying profit, underpinned by new product launches and expanding evidence linking implants to reduced dementia risk. The company’s FY26 outlook signals further gains as it advances market leadership and innovation.

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.

Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.

Phoslock Environmental Technologies prepares for ASX reinstatement with improved sales, factory refurbishment, and ongoing legal mediation.

HITIQ Limited has issued over 9.4 million shares and nearly 4.7 million options under its shortfall offer, raising $206,960 and progressing its ongoing rights issue. The company also clarified a duplicate filing and updated its issued capital structure.

Bell Financial Group reported a 44% drop in half-year net profit to $9.3 million, driven by a sharp decline in broking revenues, while its Technology & Platforms and Products & Services divisions delivered robust growth.

Bell Financial Group reported a sharp 44% drop in half-year profit to $9.3 million, citing market volatility impacting its broking segment. The company also trimmed its interim dividend to 3 cents per share, down from 4 cents.

WAM Capital Limited outperformed key ASX indices with a 22.2% portfolio increase in FY2025, declaring a strong 15.5 cents per share dividend that yields 9.1%.

HiTech Group has reported a solid 7.1% revenue increase for FY2025, driven by strong government sector demand for ICT talent and services, alongside a 10% rise in net profit after tax.

WAM Capital Limited reported a robust 22.2% investment portfolio return for FY2025, outperforming key ASX benchmarks and maintaining its full-year dividend at 15.5 cents per share with a 10% yield.

Pro Medicus has delivered a landmark FY25 with soaring revenue and profit, driven by major contract wins and strategic cloud deployments. The company’s expanding North American footprint and AI initiatives set the stage for sustained growth.

Pro Medicus Limited reports a record-breaking year with $520 million in new contracts and a surge in cloud adoption, setting the stage for continued growth. The company also advances its AI and cardiology offerings, reinforcing its market position.